Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
BPC-157 Collagen synthesis via VEGF/EGF upregulation 250–500mcg 2×/day Localised tendon/ligament injury Animal models + case reports Gold standard for tendon repair. Lacks human RCT data but clinical outcomes consistently positiv…
MOTS-C AMPK activation → mitochondrial ATP production 5–15mg SC, 2–3×/week 2–4 hours post-injection Sustained energy without stimulant crash Best metabolic foundation. Addresses cellular depletion, not symptoms Semax Enkephalin p…
GHRP-2 Ghrelin receptor agonist. Stimulates pulsatile GH release from pituitary 100mcg doses showed 35-50% IGF-1 increase in men 40-60 (clinical trial data) 100-300mcg subcutaneous 2-3x daily, pre-meal or pre-sleep GH pulse withi…
BPC-157 VEGF upregulation, angiogenesis acceleration Tendon/ligament repair, gut healing, systemic anti-inflammatory 250–500 mcg daily Subcutaneous injection near injury site or systemic Gold standard for soft tissue recovery in …
BPC-157 Upregulates VEGF receptors, accelerates angiogenesis and collagen synthesis in damaged tissue 250–500 mcg daily, subcutaneous near injury site Reduces soft-tissue repair time by 30–40% (tendon, ligament, muscle microtraum…
BPC-157 Mast cell membrane stabilisation, nitric oxide modulation Vascular permeability, histamine-induced leakage 500–2000 mcg daily Rodent models show 60% reduction in vascular leakage (Biomedicine & Pharmacotherapy, 2019) Stro…
Semaglutide Weekly Weight reduction, A1C Stable 14 days at 25°C Low. Single weekly injection Highest telehealth success rate; predictable side effects, algorithmic titration Tirzepatide Superior efficacy vs semaglutide; same remo…
Before interpreting this table, understand that peptide research for gut permeability exists primarily in preclinical models and Phase 1–2 human trials. No peptide discussed here has completed Phase 3 FDA approval specifically fo…
MOTS-c Activates AMPK and nuclear gene transcription to increase mitochondrial biogenesis Nucleus (mitochondrial-to-nuclear signaling) Preclinical (Phase I trials planned for 2026–2027) Best for increasing mitochondrial density a…
Benzodiazepines (Valium, Xanax) and Z-drugs (Ambien, Lunesta) work by enhancing GABA-A receptor activity, which induces CNS depression. They suppress neural activity across the board, producing sedation rather than physiological …
MOTS-C operates through the mitochondrial genome. Not the nuclear genome. Binding directly to mitochondrial ribosomes to upregulate genes controlling oxidative phosphorylation and fatty acid metabolism. A 2021 study in Cell Metab…
True senolytic peptides. Compounds that selectively induce apoptosis in senescent cells without affecting proliferating or quiescent cells. Remain largely theoretical. The most validated senolytics are small molecules: dasatinib …
Before selecting a peptide for REM-focused research, understanding how each compound alters specific sleep stages is essential. The table below compares DSIP, Epitalon, and GHRP-2 across mechanism, targeted sleep phase, administr…
Selective androgen receptor modulators (SARMs) and growth hormone secretagogues are often conflated in research discussions, but their mechanisms are fundamentally different. SARMs bind androgen receptors directly. Mimicking test…
PT-141 (Bremelanotide) Melanocortin receptor agonism → central arousal initiation MC3R, MC4R (hypothalamus) Subcutaneous injection 45–60 minutes 1.75mg subcutaneous Strongest Phase III data for central arousal effects; works inde…
DSIP Amplifies delta-wave oscillations in thalamus/cortex during NREM Stage 3 Increases slow-wave sleep duration by 18–34 min/night; no REM suppression 50–150mcg subcutaneous 30–60 min before bed Gradual; noticeable effects week …
Thymosin Alpha-1 T-regulatory cell upregulation, Treg/Th17 rebalancing Direct (restores immune tolerance) Indirect (reduces ongoing damage) Minimal direct effect Phase 2 human trials in autoimmune thyroiditis BPC-157 VEGF/FGF-2 u…
Research peptides for gut restoration fall into two mechanistic categories that operate through distinct biological pathways. Epithelial repair peptides. BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu. Upregulate growth factors (V…
BPC-157 Angiogenesis and mucosal repair VEGF receptor activation, nitric oxide signaling 10 mcg/kg–10 mg/kg daily Moderate. Multiple animal studies, no human RCTs Best studied for structural repair; oral bioavailability contested…
Before selecting peptides for hepatic steatosis research, understanding the distinct mechanisms, dosing requirements, and measurable endpoints for each compound prevents protocol design errors that waste research time and funding…